Research advances in mesenchymal stem cells and their exosomes in treatment of autoimmune hepatitis / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 2920-2925, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-1003285
ABSTRACT
Autoimmune hepatitis (AIH) is a type of chronic hepatitis caused by the autoimmune system attacking hepatocytes, and its chronic progression may lead to liver cirrhosis and even hepatocellular carcinoma. Currently, pharmacotherapy and liver transplantation are the main treatment methods for AIH, but both methods have their own limitations, which limits the clinical benefits of patients. Therefore, it is a critical issue to search for new therapeutic agents and methods. Recent studies have shown that mesenchymal stem cells (MSC) and their exosomes can improve the symptoms of patients with AIH by suppressing inflammatory response, enhancing the regeneration of hepatocytes, and regulating the immune system and thus have wide application prospects in the treatment of AIH. By summarizing related articles, this article reviews the possible mechanisms and application of MSC and their exosomes in the treatment of AIH, in order to provide new ideas for the clinical treatment of AIH.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Clinical Hepatology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS